Thomas Hunt
0000-0003-1227-8862
AstraZeneca UK Ltd
8 papers found
Refreshing results…
The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models
Abstract A104: AZD1390, a potent and selective orally bioavailable blood-brain barrier-penetrant ATM inhibitor, radiosensitizes and improves survival of orthotopic glioma and metastatic brain tumor models
ENaC inhibitors for the treatment of cystic fibrosis
Discovery of a novel chemotype of potent human ENaC blockers using a bioisostere approach. Part 2: α-Branched quaternary amines
Discovery of a novel chemotype of potent human ENaC blockers using a bioisostere approach. Part 1: Quaternary amines
A diastereoselective radical cyclization approach to substituted quinuclidines
A Generic and Reproducible Route to Homo- and Heteroannular Bicyclic β-Diketones via Knochel-Type 1,4-Conjugate Additions to α,β-Unsaturated Cycloalkenones
Radion Reactions To Form Vinylphosphonothioates
Missing publications? Search for publications with a matching author name.